Obesity‐induced inflammation activates various signaling pathways, impairs insulin signaling, and promotes the release of proinflammatory mediators such as TNF‐α, IL‐1β, and IL‐6, all of which contribute to IR. The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.